Where Will Trinity Biotech plc (TRIB) Stock Go Next After It Is Up 6.60% in a Week?

The market has been high on Trinity Biotech plc (TRIB) stock recently. TRIB gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Trinity Biotech plc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TRIB!

See Full TRIB Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With TRIB Stock Today?

Trinity Biotech plc (TRIB) stock is trading at $2.26 as of 10:53 AM on Friday, Oct 8, an increase of $0.01, or 0.64% from the previous closing price of $2.25. Volume today is more active than usual. So far 612,411 shares have traded compared to average volume of 129,002 shares. The stock has traded between $2.10 and $2.50 so far today.

More About Trinity Biotech plc

Trinity Biotech PLC is in the business of development, manufacture, and marketing of clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas and Rest of World of which it derives a majority of its revenues from the Americas segment. Click Here to get the full Stock Report for Trinity Biotech plc stock.